19 Oct, 2021 11:28 AM
ImpediMed Limited (ASX.IPD) is pleased to announce the PREVENT Trial successfully met its primary endpoint. This study, which provides level I evidence, demonstrated that intervention in patients wi...read more
19 Oct, 2021 08:47 AM
The securities of Impedimed Limited (‘IPD’) will be placed in trading halt at the request of IPD, pending it releasing an announcement. Unless ASX decides otherwise, the securities will ...read more
12 Oct, 2021 07:03 PM
Immutep Limited (ASX: IMM; NASDAQ: IMMP) advises that it intends to hold its 2021 Annual General Meeting, (AGM) on Friday, 26 November 2021 commencing at 10.00am (AEDT).
The Company further advis...read more
11 Oct, 2021 05:21 PM
BARD1 Life Sciences Limited (ASX:BD1) (BARD1 or the Company), advises that the Annual General Meeting is currently scheduled for 29 November 2021. The closing date for the receipt of nominations fro...read more
07 Oct, 2021 08:46 AM
Attached is a Form 605 Notice of Ceasing to be a Substantial Holder in relation to Immutep Limited completed by Australian Ethical Investment Limited.
For more information, donwload the attached ...read more
04 Oct, 2021 04:30 PM
MMJ Group Holdings Limited (ASX:MMJ) ("MMJ"), is an Australian-listed specialist investment company which offers the opportunity to invest in a global diversified portfolio holding of inve...read more